Brief: Calliditas Therapeutics Q4 Operating Loss At SEK 222.1 Million

Calliditas Therapeutics AB

24/02/2022 06:11

Feb 24 (Reuters) - Calliditas Therapeutics AB:
    * YEAR-END REPORT, 2021
    * Q4 NET SALES AMOUNTED TO SEK 31.2 MILLION AND SEK 0.4
MILLION
FOR THREE MONTHS ENDED DECEMBER 31, 2021 AND 2020, RESPECTIVELY.
    * Q4 OPERATING LOSS AMOUNTED TO SEK 222.1 MILLION AND SEK
135.9
MILLION FOR THREE MONTHS ENDED DECEMBER 31, 2021 AND 2020,
RESPECTIVELY.

Source text for Eikon:  ID:nWkr2QX5L5 
Further company coverage:  CALTX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))